Monday, September 29, 2014

Glaucoma Patients Benefit from iPad, Kindle & Nook e-Readers

Adults with glaucoma read slower when reading silently for long periods of time and are more likely to have their reading speed decrease over time, possibly as a result of reading fatigue caused by blind spots, reduced contrast sensitivity and visual field dimensions from the  damage done by their glaucoma. According to a study published in Investigative Ophthalmology & Visual Science patients with glaucoma may benefit from using e-readers such as the iPad, Nook and Kindle devices as they offer enhanced contrast adjustment and font size. These technological solutions along with the apps that are developed for them may very well help glaucoma patients read more comfortably.

If you or someone you know has questions about e-readers such as the iPad, Nook and Kindle ti help glaucoma patients read more comfortably,  please feel free to call Eyecare Medical Group, 53 Sewall Street, Portland, Maine 04102 at 888-374-2020, visit Eyecare Medical Group or facebook.com/eyecaremedicalgroup to schedule an appointment.


Tuesday, September 16, 2014

Understanding BOTOX® Might Help Treat Type 2 Diabetes

Understanding the mechanism of action of BOTOX® might be helpful in the diagnosis and treatment of Type 2 Diabetes. What do BOTOX® and Type 2 Diabetes have to do with each other you ask?

BOTOX® Cosmetic is best known as an injection for helping patient smooth fine lines and wrinkles in order to look their best. BOTOX® is also used as treatment for a number of medical conditions including migraine, urinary incontinence, profuse sweating and crossed eyes, among others. In each of these cases, BOTOX® works because it has a paralyzing effect: that is, it relaxes specific muscles, which then provides the desired effect. BOTOX® accomplishes this effect by blocking certain proteins called SNARE (Soluble NSF Attachment Protein Receptor) proteins. It turns out that SNARE proteins in the beta cells of the pancreas help the pancreas secrete insulin, thus blocking these proteins in the pancreas could lead to insulin resistance which is the hallmark of Type 2 Diabetes. Understanding this mechanism will hopefully provide researchers with new ways to diagnose and treat Type 2 Diabetes in the future.

If you or someone you know has questions about how understanding of BOTOX® mechanism of action might help in the diagnosis and treatment of Type 2 Diabetes, please feel free to call Eyecare Medical Group, 53 Sewall Street, Portland, Maine 04102 at 888-374-2020, visit Eyecare Medical Group or facebook.com/eyecaremedicalgroup to schedule an appointment.


Friday, September 12, 2014

Diabetic Retinopathy Predicts Future Cardiovascular Events


The presence and severity of diabetic retinopathy may predict future cardiovascular (CV) events such as heart attack or stroke. The relationship between diabetic retinopathy, its 4-year progression, and CV outcomes including CV death or nonfatal myocardial infarction or stroke was analyzed in participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial who also participated in the ACCORD Eye Study. The diabetic retinopathy was classified as either none, mild, moderate, or severe and whether it was worsening was also graded. The hazard of CV death or nonfatal myocardial infarction or stroke increased by 38% for every category of change in retinopathy severity and steps of progression further raised the hazard. Thus the researchers believe that both the severity of retinopathy and its progression are determinants of predisposition to CV outcomes. The retina may provide an anatomical index of the effect of metabolic and hemodynamic factors on future CV outcomes. 

If you or someone you know has questions about diabetic retinopathy and your risk of cardiovascular events, please feel free to call Eyecare Medical Group, 53 Sewall Street, Portland, Maine 04102 at 888-374-2020, visit Eyecare Medical Group or facebook.com/eyecaremedicalgroup to schedule an appointment.


Friday, September 5, 2014

Do Vitamins & Antioxidants Decrease Cataract Risk?

While not definitive, it may be possible that there is an association between your risk of cataracts and your intake of certain vitamins and antioxidants according to researchers reporting their results in the American Journal of Clinical Nutrition. Until now, studies have been inconsistent regarding the association between blood antioxidants or vitamins and risk of age-related cataract. By performing a meta analysis of 13 different studies researchers found the  lower the  level of vitamin E, α-carotene, lutein and zeaxanthin, the  greater the  risk of age-related cataract in Asian populations but not in Western populations, whereas β-Carotene, lycopene, and β-cryptoxanthin  had no significant association with risk of cataract. While these results look somewhat interesting, the question remains whether increasing intake through dietary supplements actually have any role in decreasing the risk of cataract formation.

If you or someone you know has questions about vitamins, antioxidants and your risk of cataracts, please feel free to call Eyecare Medical Group, 53 Sewall Street, Portland, Maine 04102 at 888-374-2020, visit Eyecare Medical Group or facebook.com/eyecaremedicalgroup to schedule an appointment.